According to authorities in China, a drug used in Japan to treat new strains of influenza has appeared to be effective in coronavirus patients.
An official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
Patients who were given the medicine turned negative for the virus after an average of four days after becoming positive, compared with an average of 11 days for those who were not treated with the drug.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
The largest wildfire in at least 50 years in France, which claimed one life, has now been brought under control. The fire swept through 17,000 hectare...
Read More
A yellow heatwave warning remains in place today. Hazy sunshine with a gentle coastal breeze. Daytime are forecast to reach between 30 and 32°C in the...
Read More
A major pile-up involving around ten vehicles, including a truck and a motorcycle, occurred early on the 7th of August in the Las Planas tunnel on the...
Read More
Banque Havilland (Monaco) SAM will relaunch as Moncrief Private Bank (Monaco) SAM in late 2025, following its acquisition by an international investor...
Read More
Monaco has introduced a new road safety law that bans children under 14 from using electric scooters or electric bikes on public roads. The change is ...
Read More
